Warner Chilcott Company, LLC v. Lupin Ltd., No. 14-1262 (Fed. Cir. Oct. 22, 2014)

From the Opinion

The passage below is extracted verbatim from the opening of the document. It has not been editorially summarized — consult the full opinion for the court's complete reasoning.

Lupin L td., Lupin Pharmaceuticals, Inc. , Amneal Pharmaceuticals, LLC , and Amneal Pharmaceuticals of New York, LLC (collectively, the “Defendants”) appeal from the decision of the United States District Court for the District of New Jersey , which held that claims 1 –9 (“the asserted claims”) of U.S. Patent 7,704,984 (the “’984 patent”) were not invalid for obviousness under 35 U.S.C. § 103(a) (2006). See Warner Chilcott Co. v. Lupin Ltd. , No. 3:11 -CV-05048, 2014 WL 202659 (D.N.J . Jan. 17, 2014).